Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

ClinicalTrials.gov ID: NCT05550532

Public ClinicalTrials.gov record NCT05550532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 11:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in adult participants with major depressive disorder (MDD) with moderate to severe anhedonia (ANH+) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).

Study identification

NCT ID
NCT05550532
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
444 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2022 (Actual)
Primary completion
Nov 8, 2024 (Actual)
Completion
Nov 13, 2024 (Actual)
Last update posted
Feb 13, 2026

2022 – 2024

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
43
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205 —
Sunwise Clinical Research Lafayette California 94549 —
Pacific Neuropsychiatric Specialists Orange California 92868 —
Prospective Research Innovations Inc Rancho Cucamonga California 91730 —
University of California San Diego Medical Center San Diego California 92103 —
CMB Clinical Trials Santee California 92071 —
California Neuroscience Research Sherman Oaks California 91403 —
Pacific Clinical Research Medical Group Upland California 91786 —
Next Level Clinical Trials, LLC West Covina California 91790 —
MCB Clinical Research Centers LLC Colorado Springs Colorado 80910 —
CNS Clinical Research Group Coral Springs Florida 33067 —
Sarkis Clinical Trials Gainesville Florida 32607 —
New Life Medical Research Center, Inc. Hialeah Florida 33012 —
K2 Medical Research Maitland Florida 32751 —
Vital Care Research Miami Florida 33122 —
Global Medical Institutes Miami Florida 33125 —
LCC Medical Research Institute Inc Miami Florida 33126 —
Florida Research Center Inc. Miami Florida 33174 —
Ezy Medical Research Miami Florida 33175 —
Felicidad Medical Research Miami Florida 33184 —
Bravo Health Care Center North Bay Village Florida 33141 —
APG Research LLC Orlando Florida 32803 —
Combined Research Orlando Orlando Florida 32803 —
Quantum Laboratories Pompano Beach Florida 33064 —
CDC Research Institute LLC Port Saint Lucie Florida 34952 —
Psychiatric Medicine Associates Skokie Illinois 60076 —
Tandem Clinical Research Marrero Louisiana 70072 —
CBH Health Gaithersburg Maryland 20877 —
Michigan Clinical Research Institute Ann Arbor Michigan 48105 —
Revive Research Institute Farmington Hills Michigan 48334 —
Midwest Research Group Saint Charles Missouri 63304 —
Premier Psychiatric Research Institute, LLC Lincoln Nebraska 68526 —
Erie County Medical Center Buffalo New York 14215 —
Manhattan Behavioral Medicine New York New York 10036 —
New Hope Clinical Research Charlotte North Carolina 28211 —
Monroe Biomedical Research Monroe North Carolina 28112 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Wexner Medical Center at the Ohio State University Columbus Ohio 43221 —
Conrad Clinical Research Edmond Oklahoma 73013 —
Sooner Clinical Research Oklahoma City Oklahoma 73112 —
Paradigm Research Professionals, LLC Oklahoma City Oklahoma 73118 —
Lehigh Center for Clinical Research LLC Allentown Pennsylvania 18103 —
Global Medical Institutes Moosic Pennsylvania 18507 —
Clinical Trials of South Carolina Charleston South Carolina 29406 —
Donald J Garcia Jr MD PA Austin Texas 78737 —
Relaro Medical Trials Dallas Texas 75243 —
UT Southwestern Medical Center Dallas Texas 75247-9119 —
R and H Clinical Research Stafford Texas 77477 —
Cedar Psychiatry Murray Utah 84107 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05550532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05550532 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →